🇺🇸 FDA
Pipeline program

Xarelto 2.5 mg film-coated tablets

Phase 2 small_molecule active

Quick answer

Xarelto 2.5 mg film-coated tablets for Chronic hemodialysis is a Phase 2 program (small_molecule) at Tour Hekla with 1 ClinicalTrials.gov record(s).

Program details

Company
Tour Hekla
Indication
Chronic hemodialysis
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials